Androgens and Androgen Receptors: a Clinically Neglected Sector in Breast Cancer Biology
Overview
Oncology
Authors
Affiliations
Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide.
Xia X, Huang C, Liao Y, Liu Y, He J, Guo Z J Exp Clin Cancer Res. 2019; 38(1):220.
PMID: 31126320 PMC: 6534920. DOI: 10.1186/s13046-019-1227-7.
Masili-Oku S, Bacchi C, Fernandes F, Filassi J, Baracat E, Carvalho F Rev Bras Ginecol Obstet. 2016; 38(10):512-517.
PMID: 27813039 PMC: 10309373. DOI: 10.1055/s-0036-1593854.
Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer.
Agrawal A, Ziolkowski P, Grzebieniak Z, Jelen M, Bobinski P, Agrawal S Appl Immunohistochem Mol Morphol. 2015; 24(8):550-5.
PMID: 26230371 PMC: 5010278. DOI: 10.1097/PAI.0000000000000234.
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines.
Rizza P, Barone I, Zito D, Giordano F, Lanzino M, De Amicis F Breast Cancer Res. 2014; 16(1):R21.
PMID: 24552459 PMC: 3978907. DOI: 10.1186/bcr3619.
Gasparini P, Fassan M, Cascione L, Guler G, Balci S, Irkkan C PLoS One. 2014; 9(2):e88525.
PMID: 24505496 PMC: 3914993. DOI: 10.1371/journal.pone.0088525.